Healthcare burden of pulmonary hypertension owing to lung disease and/or hypoxia

Healthcare burden of pulmonary hypertension owing to lung disease and/or hypoxia

Abstract Background Group 3 pulmonary hypertension (PH) encompasses PH owing to lung diseases and/or hypoxia. Treatment patterns, healthcare resource use, and economic burden to US payers of Group 3 PH patients were assessed. Methods This retrospective observational study extracted data from July 1,...

Full description

Bibliographic Details
Main Authors: Gustavo A. Heresi, David M. Platt, Wenyi Wang, Christine H. Divers, Vijay N. Joish, Simon A. Teal, Justin S. Yu
Format: Article
Language:English
Published: BMC 2017-04-01
Series:BMC Pulmonary Medicine
Subjects:
Pulmonary hypertension
Pulmonary arterial hypertension
Lung diseases
Hypoxia
Healthcare costs
Online Access:http://link.springer.com/article/10.1186/s12890-017-0399-1

Internet

http://link.springer.com/article/10.1186/s12890-017-0399-1

Similar Items